DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 173 filers reported holding DIPLOMAT PHARMACY INC in Q4 2016. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $162,000 | -18.6% | 40,443 | -0.2% | 0.00% | -100.0% |
| Q3 2019 | $199,000 | -19.8% | 40,543 | -0.5% | 0.00% | 0.0% |
| Q2 2019 | $248,000 | +3.3% | 40,743 | -1.5% | 0.00% | 0.0% |
| Q1 2019 | $240,000 | -56.2% | 41,354 | +1.7% | 0.00% | -50.0% |
| Q4 2018 | $548,000 | -29.9% | 40,678 | +1.0% | 0.00% | 0.0% |
| Q3 2018 | $782,000 | -21.1% | 40,277 | +3.9% | 0.00% | 0.0% |
| Q2 2018 | $991,000 | +27.5% | 38,765 | +0.5% | 0.00% | 0.0% |
| Q1 2018 | $777,000 | +0.4% | 38,562 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $774,000 | -1.9% | 38,562 | +1.2% | 0.00% | 0.0% |
| Q3 2017 | $789,000 | +43.7% | 38,102 | +2.7% | 0.00% | +100.0% |
| Q2 2017 | $549,000 | -7.3% | 37,102 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $592,000 | +26.8% | 37,102 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $467,000 | -54.6% | 37,102 | +1.1% | 0.00% | -66.7% |
| Q3 2016 | $1,028,000 | -14.1% | 36,702 | +7.3% | 0.00% | 0.0% |
| Q2 2016 | $1,197,000 | +201.5% | 34,202 | +135.8% | 0.00% | +200.0% |
| Q1 2016 | $397,000 | – | 14,502 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|